This book includes a plain text version that is designed for high accessibility. To use this version please follow this link.
Continuing Medical Conversation


What did we learn from our exclusive roundtable of senior- level medical meeting planners? That they’re worried about compliance and exhibitor attrition, coming around to the power of Strategic Meetings Management — and excited about the fact that ‘our meetings are a way to engage people throughout the whole year.’


By Christopher Durso


Lisa Astorga, CMP Director of Meetings International Society on Throm- bosis and Haemostasis (ISTH)


Ben Hainsworth Director, Congresses and Meetings Division, European Society of Cardiology (ESC)


What is the biggest challenge facing medical meeting planners right now? Felix Niespodziewanski With the changes that are taking place in health-care delivery and reimbursement, our biggest challenge is to maintain our exhibitor base. We’re starting to lose some of our largest exhibitors, because they’re feeling that we’re too broad of an organization. And some of them have switched their focus to be more visible and active with regional or even smaller chapter state meetings, and also to focus more vertically. While the college is an umbrella orga- nization for all of surgery, the largest contingent of member- ship are general surgeons, and general surgeons are sort of the steak and not the sizzle, as I say it. One of the reasons, I’ve been told, is [exhibitors] struggle now gaining access to the provider, because so few of them


PCMA.ORG


Felix Niespodziewanski Director of Convention and Meetings, American College of Surgeons (ACS)


Barbara Smith, CAE Executive Director, American Thyroid Association (ATA)


now are independent practices. They’re part of a large group, or if not a large group, they’re employees of some kind of an institution. And frequently the buying deci- sion now has been moved from their hands to someone in finance procurement, to determine what’s going to be pur- chased for the entire institution. And access to the provider has become more and more difficult for pharmaceutical and device manufacturers.


Barbara Smith I think the rigors of CME have gone over- board. This is true on all fronts. Right now, I’m in the middle of actually submitting for CME. It used to be that we would take our entire program, which has 32 hours of CME credit. Which means we have 130 faculty, all of whom volunteer their time; no one is getting paid. They don’t get honoraria.


AUGUST 2013 PCMA CONVENE 71


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112